This Government Contract opportunity from Department Of Veterans Affairs was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--VISN IDIQ LENALIDOMIDE Sole Source Justification

Closed

36C24226F0064Federal

Submission Closed05/19/2026, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supply of PYP Cold VialsThe contract involves the supply of PYP cold vials to the VA Pittsburgh facility, requiring a stringent same-day delivery service within a 2-hour window during business hours. The supplier must ensure the maintenance of the cold chain throughout the delivery process, complying with all relevant regulatory standards to preserve the integrity of the product. This contract is categorized under NAICS code 325412 and is managed by the Department of Veterans Affairs, specifically through the 244-NETWORK Contract Office 4. Responses to this subcontract opportunity must be submitted by July 10, 2026. The contract emphasizes urgency and precision in delivery, reflecting the critical nature of the supplies for the facility's operations. The detailed logistics and regulatory compliance underscore the importance of reliability and quality control in fulfilling the contract requirements. Information about the contract was made available as of June 12, 2026.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

PETNET PharmaceuticalThe Medical Readiness Contracting Office-West plans to award a firm fixed-price sole source contract to PETNET Solutions INC., doing business as Siemens Healthineers, for the supply of FDA-approved radiopharmaceuticals including FDG, NaF, Amyvid, and Posluma. The contract encompasses a base period from October 1, 2026, to September 30, 2027, with an option period extending to September 30, 2028. This contract will be executed under statutory authority FAR 12.102(a), allowing for non-competitive procurement due to the determination that only one source is reasonably available to meet the government's specific needs. The contract falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. The delivery location for the products will be the William Beaumont Army Medical Center at Fort Bliss, Texas. The notice explicitly states that no competitive proposals will be solicited, and the government will not honor any capability briefings or telephonic inquiries related to this contract. The point of contact for inquiries is Darryl O. Bryant, with a secondary contact being Karina Haddix, both representatives of the Department of Defense’s Medical Readiness Contracting Office-West.

W40M MRC0 West

POSTED

5 days ago

DEADLINE

in 6 days

AI Contract Overview

The contract is a sole-source award intended to secure a continuous and reliable supply of Lenalidomide, an immunomodulatory drug used primarily for treating multiple myeloma, anemia associated with myelodysplastic syndromes in adults, and certain lymphomas. Exelan Pharmaceuticals, based in Boca Raton, FL, has been identified as the proposed contractor responsible for providing all necessary materials, labor, and equipment required to manufacture and supply Lenalidomide. The contract mandates compliance with federal regulations, current Good Manufacturing Practices (cGMP), and FDA requirements, including adherence to the Risk Evaluation and Mitigation Strategy (REMS) program to ensure safe patient access and appropriate management of the drug’s significant risks. This action reflects an urgent need to maintain an uninterrupted supply of Lenalidomide for patient care and regulatory compliance. The Department of Veterans Affairs, through its 242-NETWORK Contract Office in Albany, NY, is overseeing the procurement. The contract relates to NAICS code 325412 and involves a specialized procurement process without a competitive solicitation, highlighting the necessity and exclusivity of the contractor’s capability to meet these specific requirements. The designated point of contact for the contract is Corey Swinton, a Contract Specialist with the VA.

General Info

Sole-source contract with Exelan Pharmaceuticals for continuous Lenalidomide supply, ensuring regulatory compliance.

Agency

Department Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Set-Aside

NONE

Documents

(2)

36F79720D0227+36C24226F0064.docx

DOCX

HCA+Signed+NCO+2+FOR+HCA+SIGNATURE+-+P03+-+Limiting+Sources+over+SAT+MDW.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 5

special-notice

Response DeadlineMay 19

Deadline has passed

Submission Closed

05/19/2026, 08:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)

Contacts1 person available

OfficeALBANY, NY, 12208, USA

Organization / Agency

Department Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)

Office AddressALBANY, NY, 12208, USA

Contacts

Corey SwintonContract Specialist

contact@example.gov

Full Description

This is a notice of intent to award a Sole-Source only contract and is not a request for quotes.
Name of Proposed Contractor Exelan Pharmaceuticals Street Address: 370 W. Camino Gardens, Suite 204 City, State, Zip: Boca Raton, FL 334432

The objective of this action is the procurement for:

The purpose of this contract is to establish a reliable and continuous supply of Lenalidomide, an immunomodulatory drug used primarily to treat multiple myeloma, anemia in myelodysplastic syndromes (MDS) in adults, and certain types of lymphoma. Lenalidomide works by enhancing the immune system s ability to fight cancer cells. It inhibits the growth of new blood vessels in tumors and alters the immune response to target and destroy malignant cells. It comes with serious risks that require careful management and monitoring.
Contractor shall provide all materials, labor, and equipment necessary to supply Lenalidomide in accordance with all applicable federal regulations, Good Manufacturing Practices (cGMP) and the Food and Drug Administration (FDA) requirements. This is an emergent need to ensure continuous supply, to meet regulatory obligations (Risk Evaluation and Mitigation Strategy REMS) program, and to support patient access.